Strides Pharma Science Limited considered and approved offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, Non-Convertible Debentures (NCDs) of face value INR 10,00,000 each aggregating up to INR 1500 million.